Creative Planning Portfolio holdings
AUM
$117B
1-Year Return
13.67%
This Quarter Return
+1.53%
1 Year Return
+13.67%
3 Year Return
+45.97%
5 Year Return
+68.1%
10 Year Return
+115.56%
AUM
$93.6B
AUM Growth
+$3.45B
(+3.8%)
Cap. Flow
+$2.48B
Cap. Flow
% of AUM
2.65%
Top 10 Holdings %
Top 10 Hldgs %
45.76%
Holding
3,128
New
281
Increased
1,798
Reduced
801
Closed
131
Top Buys
| 1 |
Vanguard Total Bond Market
BND
|
$626M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
$324M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$279M |
| 4 |
SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
$184M |
| 5 |
NVIDIA
NVDA
|
$118M |
Top Sells
Sector Composition
| 1 | Technology | 6.3% |
| 2 | Financials | 2.97% |
| 3 | Healthcare | 1.77% |
| 4 | Consumer Discretionary | 1.76% |
| 5 | Communication Services | 1.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2951
GrowGeneration
GRWG
$90.3M
| $21.7K | ﹤0.01% |
+10,081
| New | +$21.7K |
|
2952
BigBear.ai
BBAI
$1.85B
| $19.2K | ﹤0.01% |
12,693
+333
| +3% | +$503 |
|
2953
Ocugen
OCGN
$322M
| $19K | ﹤0.01% |
+12,254
| New | +$19K |
|
2954
Vuzix
VUZI
$188M
| $18.5K | ﹤0.01% |
+13,676
| New | +$18.5K |
|
|
LGVN
2955
Longeveron
LGVN
$16.5M
| $18K | ﹤0.01% |
11,200
+267
| +2% | +$430 |
|
2956
Milestone Pharmaceuticals
MIST
$153M
| $17.3K | ﹤0.01% |
13,080
| – | – |
|
2957
Butterfly Network
BFLY
$393M
| $16.7K | ﹤0.01% |
19,803
+2,835
| +17% | +$2.38K |
|
2958
Kopin
KOPN
$345M
| $15.7K | ﹤0.01% |
18,718
+7,730
| +70% | +$6.49K |
|
|
GRTS
2959
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $15.4K | ﹤0.01% |
24,910
| – | – |
|
2960
Cytosorbents Corp
CTSO
$60.6M
| $15K | ﹤0.01% |
21,295
| – | – |
|
|
SDPI
2961
DELISTED
Superior Drilling Products Inc.
SDPI
| $14.3K | ﹤0.01% |
11,000
| – | – |
|
2962
Douglas Elliman
DOUG
$257M
| $13.9K | ﹤0.01% |
12,024
| – | – |
|
|
ME
2963
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $13.7K | ﹤0.01% |
1,754
+15
| +0.9% | +$117 |
|
2964
Veru
VERU
$49.4M
| $12.8K | ﹤0.01% |
1,518
+25
| +2% | +$210 |
|
2965
Femasys
FEMY
$12.2M
| $12K | ﹤0.01% |
10,526
| – | – |
|
2966
Gevo
GEVO
$404M
| $11.1K | ﹤0.01% |
19,849
-894
| -4% | -$498 |
|
|
LILM
2967
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $10.9K | ﹤0.01% |
+13,655
| New | +$10.9K |
|
2968
Ginkgo Bioworks
DNA
$660M
| $10.7K | ﹤0.01% |
797
-444
| -36% | -$5.94K |
|
2969
Village Farms International
VFF
$301M
| $10.2K | ﹤0.01% |
10,000
-2,106
| -17% | -$2.15K |
|
2970
Gores Guggenheim
PSNY
$2.14B
| $10K | ﹤0.01% |
12,760
+2
| +0% | +$2 |
|
2971
Presidio Property Trust
SQFT
$6.93M
| $8.57K | ﹤0.01% |
1,229
| – | – |
|
2972
Westwater Resources
WWR
$61.8M
| $8.24K | ﹤0.01% |
17,111
+292
| +2% | +$141 |
|
|
BLRX
2973
BioLineRX
BLRX
$15.6M
| $7.46K | ﹤0.01% |
327
+2
| +0.6% | +$46 |
|
|
BCLI
2974
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $7.08K | ﹤0.01% |
1,395
-53
| -4% | -$269 |
|
2975
Sadot Group
SDOT
$8.93M
| $6.4K | ﹤0.01% |
1,677
| – | – |
|